Teva Pharmaceutical Industries Limited Gets Exclusivity on Plan B Contraceptive

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The US Food and Drug Administration has granted exclusive rights to Teva Pharmaceuticals to put its Plan B One-Step emergency contraceptive on drugstore shelves without any age restrictions for the next three years. The decision late Monday night means the brand-name product will be the only version available to younger teenagers, and the price — about $50 for a one-pill dose — is unlikely to drop until 2016. Critics of the decision said that will make the drug unaffordable for many teens. The FDA action comes as Plan B One-Step has started to appear in some drugstores in Boston this week, on shelves next to spermicides and pregnancy tests.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC